866-997-4948(US-Canada Toll Free)

Immunoglobulins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : Dec 2018

Category :

Pharmaceutical

No. of Pages : 188 Pages

Global Immunoglobulins Market: Overview

This report analyzes the current and future scenario of the global immunoglobulins market for the period 2018 to 2026. Rise in neurology, immunology, hematology, and other disease prevalence, high unmet medical needs, and rich pipeline are likely to be major drivers of the global immunoglobulins market during the forecast period. 

The global immunoglobulins market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on applications, route of administration, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global immunoglobulins market. 

Global Immunoglobulins Market: Key Segments

Based on application, the global immunoglobulins market has been segmented into neurology, immunology, hematology, and others. The segments have been analyzed based on available products used during the treatment of chronic diseases, and cost-effectiveness. In terms of route of administration, the global immunoglobulins market has been classified into intravenous, subcutaneous, and intramuscular. Based on end-user, the global immunoglobulins market has been divided into hospital, clinics, and homecare. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. 

Global Immunoglobulins Market: Regional Outlook

In terms of region, the global immunoglobulins market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in the Report

The report also profiles major players operating in the global Immunoglobulins market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Shire, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc, Biotest AG, Sanquin, and LFB SA. 

The global immunoglobulins market has been segmented as below:

  • Global Immunoglobulins Market, by Applications
    • Neurology
    • Immunology
    • Hematology
    • Others
  • Global Immunoglobulins Market, by Route Of Administration
    • Intravenous
    • Subcutaneous
    • Intramuscular
  • Global Immunoglobulins Market, by End-user
    • Hospital
    • Clinic
    • Homecare
  • Global Immunoglobulins Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • GCC Countries
      • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Immunoglobulins Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Immunoglobulins Market Analysis and Forecast, 2016–2026
4.4.1. Global Immunoglobulins Market Value (US$ Mn) Projections
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Regulatory Scenario by Region/globally
5.3. Pipeline Analysis

6. Global Immunoglobulins Market Analysis and Forecast, by Applications 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Immunoglobulins Market Value Forecast, by Applications, 2016–2026
6.3.1. Neurology
6.3.2. Immunology
6.3.3. Hematology
6.3.4. Others
6.4. Global Immunoglobulins Market Attractiveness by Applications 

7. Global Immunoglobulins Market Analysis and Forecast, by Route of Administration 
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
7.3.1. Intravenous
7.3.2. Subcutaneous
7.3.3. Intramuscular
7.4. Global Immunoglobulins Market Attractiveness by Route of Administration 

8. Global Immunoglobulins Market Analysis and Forecast, by End-user 
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Immunoglobulins Market Value Forecast, by End-user, 2016–2026
8.3.1. Hospital
8.3.2. Clinic
8.3.3. Homecare
8.4. Global Immunoglobulins Market Attractiveness by End-user 

9. Global Immunoglobulins Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Immunoglobulins Market Value Forecast, by Region
9.2.1. North America 
9.2.2. Europe 
9.2.3. Asia Pacific 
9.2.4. Latin America 
9.2.5. Middle East & Africa 
9.3. Global Immunoglobulins Market Attractiveness, by Country/Region

10. North America Immunoglobulins Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
10.2.1. Neurology
10.2.2. Immunology
10.2.3. Hematology
10.2.4. Others
10.3. North America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
10.3.1. Intravenous
10.3.2. Subcutaneous
10.3.3. Intramuscular
10.4. North America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Homecare
10.5 North America Immunoglobulins Market Value Forecast, by Country, 2016–2026
10.5.1. US
10.5.2. Canada 
10.6. North America Immunoglobulins Market Attractiveness Analysis 
10.6.1. By Applications 
10.6.2. By Route of Administration 
10.6.3. By End-user 
10.6.4. By Country

11. Europe Immunoglobulins Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Immunoglobulins Market Value Forecast by Applications, 2016–2026
11.2.1. Neurology
11.2.2. Immunology
11.2.3. Hematology
11.2.4. Others
11.3. Europe Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
11.3.1. Intravenous
11.3.2. Subcutaneous
11.3.3. Intramuscular
11.4. Europe Immunoglobulins Market Value Forecast, by End-user, 2016–2026
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Homecare
11.5. Europe Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Immunoglobulins Market Attractiveness Analysis 
11.6.1. By Applications 
11.6.2. By Route of Administration 
11.6.3. By End-user 
11.6.4. By Country/Sub-region

12. Asia Pacific Immunoglobulins Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Immunoglobulins Market Value Forecast, by Applications, 2016–2026
12.2.1. Neurology
12.2.2. Immunology
12.2.3. Hematology
12.2.4. Others
12.3. Asia Pacific Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
12.3.1. Intravenous
12.3.2. Subcutaneous
12.3.3. Intramuscular
12.4. Asia Pacific Immunoglobulins Market Value Forecast, by End-user, 2016–2026
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Homecare
12.5. Asia Pacific Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Immunoglobulins Market Attractiveness Analysis 
12.6.1. By Applications 
12.6.2. By Route of Administration 
12.6.3. By End-user 
12.6.4. By Country/Sub-region

13. Latin America Immunoglobulins Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
13.2.1. Neurology
13.2.2. Immunology
13.2.3. Hematology
13.2.4. Others
13.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
13.3.1. Intravenous
13.3.2. Subcutaneous
13.3.3. Intramuscular
13.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Homecare
13.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Immunoglobulins Market Attractiveness Analysis 
13.6.1. By Applications 
13.6.2. By Route of Administration 
13.6.3. By End-user 
13.6.4. By Country/Sub-region

14. Middle East & Africa Immunoglobulins Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
14.2.1. Neurology
14.2.2. Immunology
14.2.3. Hematology
14.2.4. Others
14.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
14.3.1. Intravenous
14.3.2. Subcutaneous
14.3.3. Intramuscular
14.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
14.4.1. Hospital
14.4.2. Clinic
14.4.3. Homecare
14.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Latin America Immunoglobulins Market Attractiveness Analysis 
14.6.1. By Applications 
14.6.2. By Route of Administration 
14.6.3. By End-user 
14.6.4. By Country/Sub-region
 
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share Analysis by Company (2016)
15.3. Company Profiles
15.3.1. Shire
15.3.2. CSL Behring 
15.3.3. Kedrion Biopharma Inc 
15.3.4. Grifols, S.A.
15.3.5. Octapharma
15.3.6. China Biologic Products Holdings, Inc
15.3.7. Biotest AG
15.3.8. Sanquin
15.3.9. LFB SA

List of Table

Table 01: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 02: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 03: Global Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 06: North America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 07: North America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 08: North America Immunoglobulins Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 09: Europe Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 10: Europe Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 11: Europe Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: Europe Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 13: Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 14: Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 15: Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Latin America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 18: Latin America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 19: Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
Table 22: Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
Table 23: Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

List of Chart

Figure 01: Global Immunoglobulins Market Snapshot
Figure 02: Global Immunoglobulins Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 03: Global Immunoglobulins Market Snapshot, ROA
Figure 04: Global Immunoglobulins Market Snapshot, ROA
Figure 05: Global Immunoglobulins Market Value (US$ Mn) Forecast, 2016?2026
Figure 06: Global Immunoglobulins Market Value Share, by Applications (2017)
Figure 07: Global Immunoglobulins Market Value Share, by Route of Administration (2017)
Figure 08: Global Immunoglobulins Market Value Share, by End-user (2017)
Figure 09: Global Immunoglobulins Market Value Share, by Region (2017)
Figure 10: Global Immunoglobulins Market Value Share Analysis, by Applications, 2017 and 2026
Figure 11: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Neurology, 2016–2026
Figure 12: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hematology, 2016–2026
Figure 13: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016-2026
Figure 14: Global Immunoglobulins Market Attractiveness, by Applications, 2018–2026
Figure 15: Global Immunoglobulins Market Value Share(%), by Route of Administration, 2017 and 2026
Figure 16: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2016–2026
Figure 17: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intramuscular, 2016–2026
Figure 18: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2016–2026
Figure 19: Global Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
Figure 20: Global Immunoglobulins Market Value Share(%), by End-user, 2017 and 2026
Figure 22: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinic, 2016–2026
Figure 23: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Homecare, 2016–2026
Figure 21: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital, 2016–2026
Figure 24: Global Immunoglobulins Market Attractiveness, by End-user, 2018–2026
Figure 25: Global Immunoglobulins Market Value Share Analysis, by Region 2017 and 2026
Figure 26: Global Immunoglobulins Market Attractiveness, by Region, 2018–2026
Figure 27: North America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 28: North America Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
Figure 29: North America Immunoglobulins Market Attractiveness, by Applications, 2018–2026
Figure 30: North America Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
Figure 31: North America Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
Figure 32: North America Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
Figure 33: North America Immunoglobulins Market Attractiveness, by End-user, 2018–2026
Figure 34: North America Immunoglobulins Market Value Share (%), by Country, 2017 and 2026
Figure 35: North America Immunoglobulins Market Attractiveness, by Country, 2018–2026
Figure 36: Europe Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 37: Europe Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
Figure 38: Europe Immunoglobulins Market Attractiveness, by Applications, 2018–2026
Figure 39: Europe Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
Figure 40: Europe Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
Figure 41: Europe Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
Figure 42: Europe Immunoglobulins Market Attractiveness, by End-user, 2018–2026
Figure 43: Europe Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 44: Europe Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 45: Latin America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 46: Asia Pacific Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
Figure 47: Asia Pacific Immunoglobulins Market Attractiveness, by Applications, 2018–2026
Figure 48: Asia Pacific Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
Figure 49: Asia Pacific Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
Figure 50: Asia Pacific Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
Figure 51: Asia Pacific Immunoglobulins Market Attractiveness, by End-user, 2018–2026
Figure 52: Asia Pacific Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 53: Asia Pacific Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 54: Latin America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 55: Latin America Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
Figure 56: Latin America Immunoglobulins Market Attractiveness, by Applications, 2018–2026
Figure 57: Latin America Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
Figure 58: Latin America Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
Figure 59: Latin America Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
Figure 60: Latin America Immunoglobulins Market Attractiveness, by End-user, 2018–2026
Figure 61: Latin America Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 62: Latin America Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 63: Middle East & Africa Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 64: Middle East & Africa Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
Figure 65: Middle East & Africa Immunoglobulins Market Attractiveness, by Applications, 2018–2026
Figure 66: Middle East & Africa Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
Figure 67: Middle East & Africa Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
Figure 68: Middle East & Africa Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
Figure 69: Middle East & Africa Immunoglobulins Market Attractiveness, by End-user, 2018–2026
Figure 70: Middle East & Africa Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 71: Middle East  & Africa Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 72: Global Immunoglobulins Market Share Analysis, by Company (2017)
Figure 73: Research & Development Expenses (2017)
Figure 74: Breakdown of Net Sales (% Share), by Region (2017)
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
Figure 76: Breakdown of Net Sales (% Share), by Business Segment (2017)
Figure 77: Research and Development Expenses, 2014–2018
Figure 78: Breakdown of Net Sales (% Share), by Region (2017–2018)
Figure 79: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 80: Research and Development Expenses, 2013-2017
Figure 81: Breakdown of Net Sales (% Share), by Region (2017)
Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
Figure 83: Breakdown of Net Sales (% Share), by Business Segment (2017)
Figure 84: Research and Development Expenses, 2013-2017
Figure 85: Breakdown of Net Sales (% Share), by Region (2017)
Figure 86: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
Figure 87: Breakdown of Net Sales (% Share), by Business Segment (2017)
Figure 88: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
Figure 89: Research and Development Expenses, 2013-2017
Figure 90: Breakdown of Net Sales, by Business Segment, 2017
Figure 91: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 92: Research & Development Cost, 2015–2017 (US$ Mn)
Figure 93: Breakdown of Net Sales, by Business Segment, 2017
Figure 94: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 95: Research & Development Cost, 2015–2017 (US$ Mn)
Figure 96: Breakdown of Net Sales, by Business Segment, 2017
Figure 97: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 98: Research & Development Cost, 2015–2017 (US$ Mn)
Figure 99: Breakdown of Net Sales, by Business Segment, 2017
Figure 100: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 101: Research & Development Cost, 2015–2017 (US$ Mn)
Figure 102: Breakdown of Net Sales, by Business Segment, 2017
Figure 103: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
Figure 104: Research & Development Cost, 2015–2017 (US$ Mn)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *